share_log

普利制药:关于预计无法在法定期限内披露2023年年度报告及2024年第一季度报告的风险提示性公告

Hainan Poly Pharm: An indicative notice on the risk of not being able to disclose the 2023 Annual Report and the 2024 First Quarter Report within the statutory period

Sensex a share ·  Apr 29
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more